🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this extension study was to assess the safety and efficacy o...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-01-15
Trial ID
NCT03386474
Treatments Being Tested
This was a multicenter, open label study that is designed to evaluate the s...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-05-23
Trial ID
NCT03930641
Treatments Being Tested
This was a Phase III, randomized, double-masked, multi-center, active-contr...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-07-27
Trial ID
NCT03481660
Treatments Being Tested
The purpose of this extension study was to evaluate the efficacy and safety...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-12-16
Trial ID
NCT04597632
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-07-23
Trial ID
NCT03481634
Treatments Being Tested
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-28
Trial ID
NCT02434328
Treatments Being Tested
This was a 64-week randomized, double-masked, multi-center, active-controll...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-09-25
Trial ID
NCT04005352
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Completed
Location
Retina Associates SW
Start Date
2020-11-19
Trial ID
NCT04278417
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-07-03
Trial ID
NCT03810313
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of two di...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-13
Trial ID
NCT04679935
Treatments Being Tested